Smith Hunter C: insider trades.
Smith Hunter C reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($6.6M), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Smith Hunter C
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Rhythm Pharmaceuticals, Inc. (RYTM) | Officer · Chief Financial Officer | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-31 | Rhythm Pharmaceuticals, Inc. | S | 11,514 | $105.37 | 142,212 | Form 4 |
| 2026-08-31 | Rhythm Pharmaceuticals, Inc. | S | 23,072 | $104.59 | 153,726 | Form 4 |
| 2026-08-31 | Rhythm Pharmaceuticals, Inc. | M | 57,187 | $25.79 | 176,798 | Form 4 |
| 2026-08-31 | Rhythm Pharmaceuticals, Inc. | S | 28,188 | $106.2 | 114,024 | Form 4 |
Questions
What stock did Smith Hunter C buy or sell?
Smith Hunter C reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($6.6M), across 1 company.
Is Smith Hunter C the same person as other filers with this name?
This page covers SEC CIK 1636385 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/smith-hunter-c-1636385.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.